270 related articles for article (PubMed ID: 1972746)
1. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
Touzeau PL; Shea-Donohue T
J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
3. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
4. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
5. Further study of kappa opioids on increased urination.
Leander JD
J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
7. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
9. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
Negus SS; Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
[TBL] [Abstract][Full Text] [Related]
10. Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductance.
Shen KF; Crain SM
Neuropharmacology; 1990 Apr; 29(4):343-9. PubMed ID: 1971431
[TBL] [Abstract][Full Text] [Related]
11. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
12. Kappa opiate receptor agonists: effects on behavior and on brain function and structure in rhesus monkeys.
Heath RG; Fitzjarrell AT; Walker CF
Biol Psychiatry; 1984 Jul; 19(7):1045-74. PubMed ID: 6089918
[TBL] [Abstract][Full Text] [Related]
13. Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats.
Kapusta DR; Jones SY; DiBona GF
J Pharmacol Exp Ther; 1989 Oct; 251(1):230-7. PubMed ID: 2552076
[TBL] [Abstract][Full Text] [Related]
14. Centrally-administered opioid selective agonists inhibit drinking in the rat.
Spencer RL; Deupree D; Hsiao S; Mosberg HI; Hruby V; Burks TF; Porreca F
Pharmacol Biochem Behav; 1986 Jul; 25(1):77-82. PubMed ID: 2875475
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
Ho BY; Takemori AE
J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
[TBL] [Abstract][Full Text] [Related]
16. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.
Clark JA; Liu L; Price M; Hersh B; Edelson M; Pasternak GW
J Pharmacol Exp Ther; 1989 Nov; 251(2):461-8. PubMed ID: 2553920
[TBL] [Abstract][Full Text] [Related]
17. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
Millan MJ; Morris BJ; Herz A
J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
[TBL] [Abstract][Full Text] [Related]
18. Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
Gué M; Junien JL; Bueno L
J Pharmacol Exp Ther; 1989 Sep; 250(3):1006-10. PubMed ID: 2550612
[TBL] [Abstract][Full Text] [Related]
19. Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels.
Leander JD; Hart JC; Zerbe RL
J Pharmacol Exp Ther; 1987 Jul; 242(1):33-9. PubMed ID: 3039112
[TBL] [Abstract][Full Text] [Related]
20. Differential cross-tolerance to opioid agonists in morphine-tolerant pigeons responding under a schedule of food presentation.
Craft RM; Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):386-93. PubMed ID: 2542528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
